Hepatology 74(6):32493268 Wu R, Zhu H, He Q, Yuan T, Yang B (2024) Metabolic reprogramming in kras-mutant cancers: proven targetable vulnerabilities and potential therapeutic strategies
We cooperate with factory with following standard: Natural product fermented from Saccharomyces cerevisiae
Subsequently, beneficial effects of FOXO4-DRI have been demonstrated in various age-related models 6,7,8
It may affect the liver enzymes responsible for drug metabolism (cytochrome P450 system), potentially altering the effectiveness or side effects of drugs like blood thinners (e.g., warfarin), anti-diabetic medications, statins, and some psychiatric drugs
Who Is It For
This is down to our unique technology and development process